Current situation and clinical treatment of Korean medicine in women with menstrual irregularity by polycystic ovary syndrome: an observational multi-center pilot study

Dongshin Korean Medilcine Hospital0 个研究点目标入组 19 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1. Woman aged over 20 years
•2. Those who satisfy the criteria of Polycystic Ovary Syndrome based on the Rotterdam Standard in 2003 and satisfy one of the following three criteria a) and one or more of b) and c)
•a) Menstrual irregularity or amenorrhea (menstruation was less than 8 or exceeded 35 days in the past year)
•b) Clinical hyperandrogenism or hyperandrogenemia(If the total testosterone concentration is greater than 0.68 ng / ml, the free testosterone concentration is greater than 1.72 pg / ml, or the modified Ferriman- Gallwey score is greater than or equal to 6)
•c) Polycystic ovary : On ultrasonography examination, one ovary had 12 or more follicles 2 to 9 mm in diameter or more than 10 mL of ovarian volume
•3. Who voluntarily signed to the informed consent form
•4. Who can trust the researcher, cooperate throughout the study period, comply with restrictions

•1. Who diagnosed with pituitary disease, hypothalamic disease, thyroid dysfunction, uterine tuberculosis, etc., which is a cause of menstrual irregularity.
•2. Who diagnosed with hyperprolactinemia, hyperthyroidism, and ovarian dysfunction at the screening visit
•3. Who taking another medicine such as Antidepressant, Anti-serotonin, Antipsychotic

发起方

Dongshin Korean Medilcine Hospital